Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yoko Ura"'
Autor:
Masaki Sano, Zhen Li, Yumiko Murakami, Megumi Jinno, Yoko Ura, Akihiro Kaneda, Takeshi Nakatsuka
Publikováno v:
Journal of Archaeological Science: Reports. 45:103626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::633e8ff5dd4ec261e3f23378c5d62eda
https://doi.org/10.1016/j.jasrep.2022.103626
https://doi.org/10.1016/j.jasrep.2022.103626
Autor:
Akari Kusamoto, Miyuki Harada, Ayaka Minemura, Asami Matsumoto, Kentaro Oka, Motomichi Takahashi, Nanoka Sakaguchi, Jerilee M. K. Azhary, Hiroshi Koike, Zixin Xu, Tsurugi Tanaka, Yoko Urata, Chisato Kunitomi, Nozomi Takahashi, Osamu Wada-Hiraike, Yasushi Hirota, Yutaka Osuga
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
The gut microbiome is implicated in the pathogenesis of polycystic ovary syndrome (PCOS), and prenatal androgen exposure is involved in the development of PCOS in later life. Our previous study of a mouse model of PCOS induced by prenatal dihydrotest
Externí odkaz:
https://doaj.org/article/90b5c734052349d09fdd929a2b8053ed
Autor:
Yoko Urata, Miyuki Harada, Shinnosuke Komiya, Ikumi Akiyama, Chihiro Tuchida, Yoshiharu Nakaoka, Aisaku Fukuda, Yoshiharu Morimoto, Takuya Kawahara, Yusuke Ishikawa, Yutaka Osuga
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveA Mediterranean dietary pattern, sleeping habits, physical activity, and lifestyle appear to affect reproductive health. There are few reports about whether fertility-specific quality of life (QOL) is linked to infertility treatment outcomes
Externí odkaz:
https://doaj.org/article/0f14e11df5584692a42ba49d35cf35f0
Autor:
Yoko Urata, Reza Salehi, Brandon A. Wyse, Sahar Jahangiri, Clifford L. Librach, Chii-Ruey Tzeng, Yutaka Osuga, Benjamin Tsang
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-10 (2023)
Abstract Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is
Externí odkaz:
https://doaj.org/article/d9a718d3579a40b1a77be5b484b88035
Autor:
Reza Salehi, Brandon A. Wyse, Meshach Asare-Werehene, Fereshteh Esfandiarinezhad, Atefeh Abedini, Bo Pan, Yoko Urata, Alex Gutsol, Jose L. Vinas, Sahar Jahangiri, Kai Xue, Yunping Xue, Kevin D. Burns, Barbara Vanderhyden, Julang Li, Yutaka Osuga, Dylan Burger, Seang-Lin Tan, Clifford L. Librach, Benjamin K. Tsang
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-20 (2023)
Abstract Polycystic ovarian syndrome (PCOS) is a complex multi-factorial syndrome associated with androgen excess and anovulatory infertility. In the current study, we investigated the role of dihydrotestosterone-induced exosomal miR-379-5p release i
Externí odkaz:
https://doaj.org/article/a018650fac1c4fa4bc44b5269fea638a
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 30(6)
Cellulose, a main component of cell walls, generally makes materials hard and brittle. However, an ultratough, cellulosic material is found in nature: cherry bark. Surprisingly, it elongates by more than twice of its initial length and behaves as a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af2e403a7014c23e580d6c6d68f2e1b6
https://pubmed.ncbi.nlm.nih.gov/29314263
https://pubmed.ncbi.nlm.nih.gov/29314263
Autor:
Zixin Xu, Nozomi Takahashi, Miyuki Harada, Chisato Kunitomi, Akari Kusamoto, Hiroshi Koike, Tsurugi Tanaka, Nanoka Sakaguchi, Yoko Urata, Osamu Wada-Hiraike, Yasushi Hirota, Yutaka Osuga
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17193 (2023)
Young female cancer patients can develop chemotherapy-induced primary ovarian insufficiency (POI). Cyclophosphamide (Cy) is one of the most widely used chemotherapies and has the highest risk of damaging the ovaries. Recent studies elucidated the piv
Externí odkaz:
https://doaj.org/article/5b81eeecfffb4dfe90dfd6c5fc5ef536
Autor:
Takuro Kobori, Rina Doukuni, Honami Ishikawa, Yui Ito, Rie Okada, Chihiro Tanaka, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Publikováno v:
Immuno, Vol 2, Iss 1, Pp 68-84 (2022)
Immune checkpoint blockade (ICB) therapies, such as immune checkpoint inhibitors against programmed death ligand-1 (PD-L1), have not been successful in treating patients with pancreatic ductal adenocarcinoma (PDAC). Despite the critical role of PD-L1
Externí odkaz:
https://doaj.org/article/53eb69fc060d4a25ada95fd0fcb3c881
Autor:
Hiroshi Koike, Miyuki Harada, Akari Kusamoto, Zixin Xu, Tsurugi Tanaka, Nanoka Sakaguchi, Chisato Kunitomi, Jerilee M. K. Azhary, Nozomi Takahashi, Yoko Urata, Yutaka Osuga
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-age women, affecting up to 15% of women in this group, and the most common cause of anovulatory infertility. Although its etiology remains unclear, recent resea
Externí odkaz:
https://doaj.org/article/78254a89a6ed46cda49a8549473da9a6
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1117 (2023)
In the past decade, immune checkpoint inhibitors have exhibited potent antitumor efficacy against multiple solid malignancies but limited efficacy against pancreatic ductal adenocarcinoma (PDAC). Cluster of differentiation (CD) 47, a member of the im
Externí odkaz:
https://doaj.org/article/2a69b17c9c9b490cbc1283e8e21a9db3